Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05086731 · ClinicalTrials.gov registry record · NA
Mobile Health to Improve Oral Chemotherapy Adherence Among Women With Breast Cancer
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 33
- Enrollment target
NCT05086731 is a NA study that has completed, run by Emory University. The registered enrollment target is 33 participants.
The verdict
NCT05086731, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
Study Summary
This clinical trial evaluates the feasibility and acceptability of a mobile health device in improving oral chemotherapy adherence in women with triple negative breast cancer that has not spread to other places in the body (non-metastatic). A mobile health device, called SMRxT smart pill bottle may help doctors to remind patients to take medicine on time and monitor their symptoms.
Interventions
- OTHER Quality-of-Life Assessment
- OTHER Survey Administration
- OTHER Medical Device Usage and Evaluation
- OTHER Best Practice
- OTHER Informational Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2021-10-22 |
| Est. Completion | 2024-03-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05086731
The ClinicalTrials.gov registry entry for NCT05086731 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Quality-of-Life Assessment is the first listed.
NCT05086731 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05086731 about?
NCT05086731 is a clinical study titled "Mobile Health to Improve Oral Chemotherapy Adherence Among Women With Breast Cancer". This clinical trial evaluates the feasibility and acceptability of a mobile health device in improving oral chemotherapy adherence in women with triple negative breast cancer that has not spread to other places in the body (non-metastatic). A mobile health device, called SMRxT smart pill bottle may ...
What is the current status of trial NCT05086731?
This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2021-10-22. Estimated completion is 2024-03-06.
What interventions are being tested in trial NCT05086731?
The interventions under investigation include: Quality-of-Life Assessment (OTHER), Survey Administration (OTHER), Medical Device Usage and Evaluation (OTHER), Best Practice (OTHER), Informational Intervention (OTHER).
Who is sponsoring clinical trial NCT05086731?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.